AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Lilly’s Hong Kong AI Biotech Deal Highlights the Globalization of Drug Discovery Partnerships
The Financial Times reports Eli Lilly is signing a multibillion-dollar AI drug development deal with a Hong Kong biotech, underscoring how geographic boundaries in pharmaceutical innovation are fading. The significance is not just the size of the agreement, but the normalization of cross-border AI sourcing as a mainstream R&D strategy.
Roche and NVIDIA Expand the AI Factory Model From Concept to Industrial Strategy
A new report on Roche and NVIDIA’s drug-discovery AI factory underscores how major pharma companies are scaling compute, data infrastructure, and model development together rather than treating AI as a side project. The significance lies in the operating model: AI in pharma is becoming capital infrastructure, not just software experimentation.
PharmaMar and Globant Bring AI to Oncology Research, Underscoring the Build-vs-Partner Reality
PharmaMar’s collaboration with Globant to accelerate oncology research illustrates how mid-sized and specialist biopharma companies are turning to external partners to operationalize AI. The deal reflects a broader market dynamic: not every company will build proprietary AI stacks, but many still want targeted advantage in discovery and translational work.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.